Minas, Tsion Zewdu
Lord, Brittany D. http://orcid.org/0000-0002-6133-1757
Zhang, Amy L.
Candia, Julián http://orcid.org/0000-0001-5793-8989
Dorsey, Tiffany H.
Baker, Francine S. http://orcid.org/0000-0003-3133-3652
Tang, Wei http://orcid.org/0000-0002-7089-4391
Bailey-Whyte, Maeve
Smith, Cheryl J.
Obadi, Obadi M.
Ajao, Anuoluwapo
Jordan, Symone V.
Tettey, Yao
Biritwum, Richard B.
Adjei, Andrew A.
Mensah, James E.
Hoover, Robert N.
Hsing, Ann W.
Liu, Jia
Loffredo, Christopher A.
Yates, Clayton http://orcid.org/0000-0001-5420-9852
Cook, Michael B.
Ambs, Stefan http://orcid.org/0000-0001-7651-9309
Funding for this research was provided by:
U.S. Department of Defense (W81XWH1810588)
Article History
Received: 17 August 2022
Accepted: 3 July 2023
First Online: 19 July 2023
Competing interests
: C.Y. received honorarium or consultant fees from PreludeDx, QED Therapeutics, Amgen, Regeneron, and Riptide Biosciences. C.Y. is a shareholder in Riptide Biosciences. The remaining authors declare that they have no competing interests.